Good Biotech Corp. is a pioneering biopharmaceutical company specializing in novel duck IgY(ΔFc) antibody technology. As a leader in polyclonal antibody manufacturing and integrated immunodiagnostics, we have developed a validated platform leveraging ducks as bioreactors to produce high-quality IgY(ΔFc) antibodies. Our innovations span immunodiagnostics, biotherapeutics, oral nutraceuticals, functional foods, and oral healthcare solutions. We are the only company capable of large-scale industrial production of duck IgY(ΔFc) antibodies. Established in 1998, Good Biotech builds on decades of biotechnology expertise and remains at the forefront of avian antibody technology.
Industry Leadership in Immunodiagnostics
Good Biotech was the first company to successfully commercialize avian-antibody-based immunodiagnostic assay kits, achieving FDA 510(k) clearance and CE Marking certification. Our duck IgY(ΔFc) antibodies offer superior sensitivity, precision, and accuracy, overcoming common interferences seen with traditional mammalian antibodies. These advantages position our immunodiagnostic kits among the highest-quality diagnostic reagents available worldwide.
Research & Development
Committed to innovation, Good Biotech continuously enhances its product portfolio and develops groundbreaking solutions to address unmet medical needs. Our advanced IgY(ΔFc) antibody technology has been successfully applied in various fields, demonstrating its validated performance and effectiveness.
- Biotherapeutics: Snake antivenom immunoglobulins, Digoxin Immune Fab (for digoxin toxicity and severe preeclampsia), and neutralizing antibodies targeting multidrug-resistant (MDR) bacterial infections.
- Nutraceuticals & Functional Health Foods: Anti-obesity formulations, gastrointestinal health products, and anti-caries oral healthcare solutions.
- Infectious Disease Solutions: Collaboration with Academia Sinica for anti-SARS IgY(ΔFc) antibody development, demonstrating potential for rapid-response biotherapeutics against emerging pathogens.
Advantages of IgY(ΔFc) Antibody Technology
Our innovative duck IgY(ΔFc) antibody platform offers significant advantages:
- High Productivity & Cost-Effectiveness: Scalable industrial production ensures a consistent supply at competitive costs.
- Enhanced Safety: Free from transmissible spongiform encephalopathies (TSEs) and non-allergenic.
- Ethical & Sustainable: Conforms to animal protection guidelines while meeting global healthcare needs.
Innovations in Immunoturbidimetric Assays & POCT
Good Biotech has developed a new generation of immunoturbidimetric assays using duck IgY(ΔFc) antibodies, surpassing traditional mammalian antibody-based assays in accuracy and performance. We were invited by a leading U.S. CDC researcher to participate in a study on the standardization of high-sensitivity CRP (hsCRP) immunoassays, contributing as one of the selected manufacturers to this important research and underscoring our expertise in diagnostic innovation.
Our Point-of-Care Testing (POCT) solutions provide rapid, quantitative results for critical care settings, including:
- IgY(ΔFc) antibody derived New Generation Immunoturbidimetry Point-of-Care (POC) diagnostic tests on POCT devices for Healthcare Professionals
- Whole Blood CRP POCT: Delivers fast, precise CRP measurements within 2–3 minutes for use in hospitals, ICUs, emergency departments, and clinics.
- Snake Venom POCT Kit: A one-step, visual rapid test for snake envenomation, enabling immediate identification and faster treatment decisions, especially in resource-limited settings.
Business Focus Areas
- Immunodiagnostics: Advanced immunoassays for clinical chemistry analyzers.
- Point-of-Care Testing (POCT): Portable, easy-to-use diagnostics for healthcare professionals.
- Biotherapeutics: Development of IgY(ΔFc)-based antivenoms, antitoxins, and neutralizing antibodies for MDR bacterial infections and critical care applications.
- Nutraceuticals & Healthcare: IgY(ΔFc)-based functional foods, oral health products, and skin healthcare solutions.
- Life Sciences & R&D: IgY(ΔFc) antibody-derived depletion columns and research tools.
At Good Biotech, we are committed to transforming healthcare through innovative IgY(ΔFc) antibody technology, advancing medical treatments, and improving quality of life worldwide.